Diagnotix introduces the thrid psychotropic medication panel for antidepressants
Diagnotix introduces the thrid psychotropic medication panel for antidepressants
Diagnotix Expands TDM Solutions with New PS 3 Panel for Antidepressants
Diagnotix proudly announces the introduction of its third panel for therapeutic drug monitoring (TDM) analyses by LC-MS. Complementing the existing PS 1 panel for tricyclic antidepressants and the PS 2 panel for neuroleptics, the new PS 3 panel focuses on other commonly used antidepressants.
The PS 3 panel includes the following analytes:
Citalopram
Norcitalopram
Fluoxetine
Norfluoxetine
Fluvoxamine
Mirtazapine
Normirtazapine
Paroxetine
Sertraline
Norsertraline
Venlafaxine
Norvenlafaxine
With the addition of PS 3, Diagnotix now offers solutions for over 95% of the most commonly prescribed psychotropic medications, ensuring comprehensive TDM coverage.
Optimized Design for Maximum Efficiency
Our panels have been carefully designed to balance a broad range of analytes with cost-efficiency. Smaller, focused panels provide distinct advantages:
Reduced Costs: Lower expenses for internal standards of rare compounds.
Improved Chromatographic Performance: Better optimization of chromatography conditions.
To maximize the capabilities of your advanced LC-MS system, each panel includes tailored mobile phases and a dedicated column, instead of a one-size-fits-all approach. This ensures superior performance and allows you to fully benefit from the technological potential of your equipment.
Diagnotix remains committed to providing innovative and reliable solutions for LC-MS-based TDM analyses. Contact us today to learn more about our panels and how they can support your laboratory's needs.

Webinar Modernizing LC-MS workflows: Case study overcoming Vitamin A&E challenges and embracing innovation
